Cor Vasa 2012, 54(5-6):e156-e161 | DOI: 10.1016/j.crvasa.2012.05.010

Percutaneous exclusion of the left atrial appendage in prevention of systemic embolism

Josef Šťáseka, Josef Bisa, Zdeněk Vaveraa, Jan Vojáčeka, Jaroslav Dušeka, Miroslav Brtkob, Pavel Polanskýb, Petr Pařízeka, Abdul Al Mawiria
a I. interní kardioangiologická klinika, Lékařská fakulta Univerzity Karlovy v Hradci Králové a Fakultní nemocnice Hradec Králové, Hradec Králové, Česká republika
b Kardiochirurgická klinika, Lékařská fakulta Univerzity Karlovy v Hradci Králové a Fakultní nemocnice Hradec Králové, Hradec Králové, Česká republika

Keywords: AMPLATZER Cardiac Plug; Anticoagulation therapy; Atrial fibrillation; Left atrial appendage; Systemic embolism

Received: May 9, 2012; Revised: May 25, 2012; Accepted: May 25, 2012; Published: May 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šťásek J, Bis J, Vavera Z, Vojáček J, Dušek J, Brtko M, et al.. Percutaneous exclusion of the left atrial appendage in prevention of systemic embolism. Cor Vasa. 2012;54(5-6):e156-161. doi: 10.1016/j.crvasa.2012.05.010.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001;285:2370-5. Go to original source... Go to PubMed...
    2. Crystal E, Connolly SJ. Role of oral anticoagulation in management of atrial fibrillation. Heart 2004;90:813-7. Go to original source... Go to PubMed...
    3. Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study, et al. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57. Go to original source...
    4. Onalan O, Crystal E. Left atrial appendage exclusion for stroke prevention in patients with non-rheumatic atrial fibrillation. Stroke 2007;38:624-30. Go to original source... Go to PubMed...
    5. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke incardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61:755-9. Go to original source... Go to PubMed...
    6. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492-501. Go to original source... Go to PubMed...
    7. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrilation. Ann Intern Med 2007;146:857-67. Go to original source... Go to PubMed...
    8. ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006;367:1903-12. Go to original source...
    9. Holmes DR Jr, Schwartz RS. Left atrial appendage occlusion eliminates the need for warfarin. Circulation 2009;120:1919-26; discussion 1926. Go to original source... Go to PubMed...
    10. Onalan O, Lashevsky I, Hamad A, Crystal E. Nonpharmacologic stroke prevention in atrial fibrillation. Exp Rev Cardiovasc Ther 2005;3:619-33. Go to original source... Go to PubMed...
    11. Kanderian AS, Gillinov AM, Pettersson GB, Klein AL. Success of surgical left atrial appendage occlusion techniques assessed by transesophageal echocardiography. J Am Coll Cardiol 2006;47:152A.
    12. Garcia-Fernandez MA, Perez-David E, Quiles J, Peralta J, Garcia-Rojas I, Bermejo J, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol 2003;42:1253-8. Go to original source... Go to PubMed...
    13. Crystal E, Lamy A, Connolly SJ, Kleine P, Hohnloser SH, Semelhago L, et al. Left atrial appendage occlusion study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention. Am Heart J 2003;145:174-8. Go to original source... Go to PubMed...
    14. Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, et al. Left atrial appendage occlusion study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005;150:288-93. Go to original source... Go to PubMed...
    15. Katz ES, Tsiamtsiouris T, Applebaum RM, Schwartzbard A, Tunick PA, Kronzon I. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol 2000;36:468-71. Go to original source...
    16. Odell JA, Blackshear JL, Davies E, Byrne WJ, Kollmorgen CF, Edwards WD, Orszulak TA. Thoracoscopic obliteration of the left atrial appendage: potential for stroke reduction. Ann Thorac Surg 1996;61:565-9. Go to original source... Go to PubMed...
    17. Blackshear JL, Johnson WD, Odell JA, Baker VS, Howard M, Pearce L, et al. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol 2003;42:1249-52. Go to original source...
    18. Kamohara K, Fukamachi K, Ootaki Y, Akiyama M, Zahr F, Kopcak MW, et al. A novel device for left atrial appendage exclusion. J Thorac Cardiovasc Surg 2005;130:1639-44. Go to original source... Go to PubMed...
    19. Wolf RK, Schneeberger EW, Osterday R, Miller D, Merrill W, Flege JB Jr, Gillinov AM. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg 2005;130:797-802. Go to original source... Go to PubMed...
    20. Balkhy HH, Chapman PD, Arnsdorf SE. Minimally invasive atrial fibrillation ablation combined with a new technique for thoracoscopic stapling of the left atrial appendage: case report. Heart Surg Forum 2004;7:353-5. Go to original source... Go to PubMed...
    21. Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation - early clinical experience. Circulation 2002;105:1887-9. Go to original source...
    22. Nakai T, Lesh MD, Gerstenfeld EP, Virmani R, Jones R, Lee RJ. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation 2002;105:2217-22. Go to original source...
    23. Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003;60:417-22. Go to original source... Go to PubMed...
    24. Stöllberger C, Schneider B, Finsterer J. Elimination of the left atrial appendage to prevent stroke or embolism? Anatomic, physiologic, and pathophysiologic considerations. Chest 2003;124:2356-62. Go to original source... Go to PubMed...
    25. Ostermayer SH, Reisman M, Kramer PH, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol 2005;46:9-14. Go to original source... Go to PubMed...
    26. Sick PB, Schuler G, Hauptmann KE, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007;49:1490-5. Go to original source... Go to PubMed...
    27. Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv 2011;77:700-6. Go to original source... Go to PubMed...
    28. Protect AF-WATCHMAN left atrial appendage system for embolic protection in patients with atrial fibrillation. Available at: www.clinicaltrials.gov/ct/show/nct00129545?Order_1. Accessed April 9, 2006.
    29. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Sick P; PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-42. Go to original source... Go to PubMed...
    30. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011; 123:417-24. Epub 2011 Jan 17. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes